Angus G. Jones

6.9k citations

77 papers · 3.1k indexed · 3 hit papers · h-index 28

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Management and Research 46
- Diabetes Treatment and Management 33
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
Genetics top 1%
- Diabetes and associated disorders 39
Surgery top 2%
- Pancreatic function and diabetes 35
Health Information Management top 2%
Family Practice top 10%
Molecular Biology
- Metabolism, Diabetes, and Cancer 9
Statistics and Probability
- Statistical Methods in Clinical Trials 5
Physiology
- Diet and metabolism studies 4

Co-authors: Andrew T. Hattersley Beverley M. Shields Timothy J. McDonald John Dennis Richard A. Oram Bridget Knight William Henley Anita Hill
Cited by: Endocrinology, Diabetes and Metabolism Genetics Surgery
Journals: The Lancet (1 paper)Nature Medicine (2 papers)SHILAP Revista de lepidopterología (3 papers)
Partner nations: United Kingdom United States Uganda

In The Last Decade

Angus G. Jones

74 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Angus G. Jones

Since Specialization

Citations

This map shows the geographic impact of Angus G. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angus G. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angus G. Jones more than expected).

Fields of papers citing papers by Angus G. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angus G. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angus G. Jones. The network helps show where Angus G. Jones may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Angus G. Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angus G. Jones Line = papers co-authored together Angus G. Jones links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection Diabetologia ·Thijs T Jansz,Katherine Young,Rhian Hopkins,Andrew McGovern,Beverley M. Shields,Andrew T. Hattersley,Angus G. Jones,Ewan R. Pearson,Coralie Bingham,Richard A. Oram,John Dennis	2025	1
2	Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach Diabetologia ·Laura M. Güdemann,Katie G. Young,Nicholas J. Thomas,Rhian Hopkins,Robert Challen,Angus G. Jones,Andrew T. Hattersley,Ewan R. Pearson,Beverley M. Shields,Jack Bowden,John Dennis,Andrew McGovern	2024	9
3	Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes Diabetologia ·Pedro Cardoso,Katherine Young,Anand Thakarakkattil Narayanan Nair,Rhian Hopkins,Andrew McGovern,Eram Haider,Piyumanga Karunaratne,Louise A. Donnelly,Bilal A. Mateen,Naveed Sattar,Rury R. Holman,Jack Bowden,Andrew T. Hattersley,Ewan R. Pearson,Angus G. Jones,Beverley M. Shields,Trevelyan J. McKinley,John Dennis	2024	12
4	The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth The Journal of Clinical Endocrinology & Metabolism ·Guido Alarcon,Anh Minh Nguyen,Angus G. Jones,Beverley M. Shields,María J. Redondo,Mustafa Tosur	2024	1
5	Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors medRxiv ·Katherine Young,Eram Haider McInnes,Robert Massey,Anna R Kahkohska,Scott J. Pilla,Sridharan Raghaven,Maggie A. Stanislawski,Deirdre K. Tobias,Andrew McGovern,Adem Y. Dawed,Angus G. Jones,Ewan R. Pearson,John Dennis	2023	2
6	Islet Autoantibody Level Distribution in Type 1 Diabetes and Their Association With Genetic and Clinical Characteristics The Journal of Clinical Endocrinology & Metabolism ·Sian Grace,Jack Bowden,Helen C. Walkey,Akaal Kaur,Shivani Misra,Beverley M. Shields,Trevelyan J. McKinley,Nick Oliver,Timothy J. McDonald,Desmond G. Johnston,Angus G. Jones,Kashyap Patel	2022	8
7	Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study Nature Medicine ·Beverley M. Shields,John Dennis,Catherine Angwin,Fiona C Warren,William Henley,Andrew Farmer,Naveed Sattar,Rury R. Holman,Angus G. Jones,Ewan R. Pearson,Andrew T. Hattersley,(unknown)	2022	27
8	The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis Diabetologia ·Katherine Young,Andrew McGovern,Inês Barroso,Andrew T. Hattersley,Angus G. Jones,Beverley M. Shields,Nicholas J. Thomas,John Dennis	2022	4
9	Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches Journal of Clinical Epidemiology ·Nicholas J. Thomas,Andrew McGovern,Katherine Young,Seth A. Sharp,Michael N. Weedon,Andrew T. Hattersley,John Dennis,Angus G. Jones	2022	14
10	Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes Diabetologia ·Davis Kibirige,Isaac Sekitoleko,William Lumu,Angus G. Jones,Andrew T. Hattersley,Liam Smeeth,Moffat Nyirenda	2022	31
11	Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study Nature Medicine ·Beverley M. Shields,Catherine Angwin,Maggie Shepherd,Nicky Britten,Angus G. Jones,Naveed Sattar,Rury R. Holman,Ewan R. Pearson,Andrew T. Hattersley	2022	8
12	Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study BMJ Open Diabetes Research & Care ·Anxious J. Niwaha,Lauren R. Rodgers,Alice L. J. Carr,Priscilla Balungi,Raymond Mwebaze,Andrew T. Hattersley,Beverley M. Shields,Moffat Nyirenda,Angus G. Jones	2022	3
13	Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes Diabetes Care ·Angus G. Jones,Timothy J. McDonald,Beverley M. Shields,William Hagopian,Andrew T. Hattersley	2021	56
14	HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study BMJ Open Diabetes Research & Care ·Anxious J. Niwaha,Lauren R. Rodgers,Rosamund Greiner,Priscilla Balungi,Raymond Mwebaze,Timothy J. McDonald,Andrew T. Hattersley,Beverley M. Shields,Moffat Nyirenda,Angus G. Jones	2021	4
15	Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation BMJ Open Diabetes Research & Care ·Andrew McGovern,Michael A. Hogg,Beverley M. Shields,Naveed Sattar,Rury R. Holman,Ewan R. Pearson,Andrew T. Hattersley,Angus G. Jones,John Dennis	2020	62
16	TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol BMJ Open ·Catherine Angwin,Caroline Jenkinson,Angus G. Jones,Christopher Jennison,William Henley,Andrew Farmer,Naveed Sattar,Rury R. Holman,Ewan R. Pearson,Beverley M. Shields,Andrew T. Hattersley	2020	13
17	Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010–2017 Diabetes Obesity and Metabolism ·John Dennis,William Henley,Andrew McGovern,Andrew Farmer,Naveed Sattar,Rury R. Holman,Ewan R. Pearson,Andrew T. Hattersley,Beverley M. Shields,Angus G. Jones	2019	68
18	Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA_1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice? Diabetic Medicine ·Shannon M Marren,S. Hammersley,Timothy J. McDonald,Beverley M. Shields,Bridget Knight,Anita Hill,R. F. Bolt,Timothy Tree,Bart O. Roep,Andrew T. Hattersley,Angus G. Jones,Richard A. Oram	2019	27
19	Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years BMJ Open ·Anita L. Lynam,Timothy J. McDonald,Anita Hill,John Dennis,Richard A. Oram,Ewan R. Pearson,Michael N. Weedon,Andrew T. Hattersley,Katharine R. Owen,Beverley M. Shields,Angus G. Jones	2019	44
20	A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy Diabetes Care ·Anita L. Grubb,Timothy J. McDonald,Femke Rutters,Louise A. Donnelly,Andrew T. Hattersley,Richard A. Oram,(unknown),Amber A. van der Heijden,Fiona Carr,Petra J. M. Elders,Michael N. Weedon,Roderick C. Slieker,Leen M. ‘t Hart,Ewan R. Pearson,Beverley M. Shields,Angus G. Jones	2018	38

About Angus G. Jones

Angus G. Jones is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery, having authored 77 papers that have together received 3.1k indexed citations. Recurring topics across this work include Diabetes Management and Research (46 papers), Diabetes and associated disorders (39 papers), Pancreatic function and diabetes (35 papers), Diabetes Treatment and Management (33 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Metabolism, Diabetes, and Cancer (9 papers), Statistical Methods in Clinical Trials (5 papers) and Diet and metabolism studies (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.0k citations), Genetics (1.5k citations) and Surgery (1.4k citations). Angus G. Jones has collaborated with scholars based in United Kingdom, United States and Uganda. Frequent co-authors include Andrew T. Hattersley, Beverley M. Shields, Timothy J. McDonald, John Dennis, Richard A. Oram, Bridget Knight, William Henley, Anita Hill, Michael N. Weedon and Rachel Besser. Their work appears in journals such as The Lancet, Nature Medicine and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact